SCHEMBL3728504

SCHEMBL3728504

Nc1nnc(COc2ccc(F)cc2Cl)s1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
RAB9A P51151 3/20 0.56
HPGD P15428 3/20 0.56
NPC1 O15118 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HTT P42858 2/20 0.52
MAPT P10636 1/20 0.52
HSD17B10 Q99714 2/20 0.47
ALOX15 P16050 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
LMNA P02545 2/20 0.46
PKM P14618 1/20 0.46
POLB P06746 3/20 0.43
MAPK1 P28482 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3728220 0.89 ALDH1A1 (0.52) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2
SCHEMBL3727149 0.86 ALDH1A1 (0.58) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2
SCHEMBL3729659 0.86 RAB9A (0.58) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2
SCHEMBL3726140 0.83 LMNA (0.62) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2
SCHEMBL3729052 0.82 HTT (0.74) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2
SCHEMBL30282807 0.82 HTT (0.74) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2
SCHEMBL3737263 0.81 RAB9A (0.53) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2
SCHEMBL3738421 0.81 ALDH1A1 (0.58) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2
SCHEMBL3729145 0.78 ALDH1A1 (0.52) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2
SCHEMBL3731106 0.77 ALDH1A1 (0.55) ALDH1A1RAB9AHPGDNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120669-A1 THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE BOUILLOT ANNE MARIE JEANNE 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120669-A1 THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE SCD, SCD5, FADS2 ALDH1A1 458/4885RAB9A 3330/4885HPGD 203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.